SG Americas Securities LLC Increases Stake in Sotera Health Company $SHC

SG Americas Securities LLC raised its holdings in Sotera Health Company (NASDAQ:SHC) by 388.6% in the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 45,333 shares of the company’s stock after buying an additional 36,055 shares during the period. SG Americas Securities LLC’s holdings in Sotera Health were worth $713,000 as of its most recent SEC filing.

Other large investors have also modified their holdings of the company. Sculptor Capital LP boosted its holdings in Sotera Health by 27.2% in the second quarter. Sculptor Capital LP now owns 11,500,000 shares of the company’s stock valued at $127,880,000 after purchasing an additional 2,462,489 shares during the period. MIG Capital LLC boosted its stake in shares of Sotera Health by 3.3% in the 2nd quarter. MIG Capital LLC now owns 5,282,339 shares of the company’s stock valued at $58,740,000 after buying an additional 168,388 shares during the period. Two Seas Capital LP grew its position in shares of Sotera Health by 21.1% during the second quarter. Two Seas Capital LP now owns 4,020,867 shares of the company’s stock worth $44,712,000 after buying an additional 699,731 shares in the last quarter. Geode Capital Management LLC increased its stake in shares of Sotera Health by 1.9% during the second quarter. Geode Capital Management LLC now owns 2,913,391 shares of the company’s stock worth $32,402,000 after buying an additional 53,654 shares during the period. Finally, Bank of America Corp DE raised its holdings in Sotera Health by 40.2% in the second quarter. Bank of America Corp DE now owns 916,156 shares of the company’s stock valued at $10,188,000 after acquiring an additional 262,772 shares in the last quarter. Hedge funds and other institutional investors own 91.03% of the company’s stock.

Analyst Ratings Changes

A number of brokerages have commented on SHC. Piper Sandler raised shares of Sotera Health from a “neutral” rating to an “overweight” rating and increased their price objective for the company from $17.00 to $24.00 in a research report on Friday, January 9th. William Blair started coverage on Sotera Health in a report on Thursday, December 18th. They issued an “outperform” rating on the stock. Barclays raised their price target on Sotera Health from $19.00 to $20.00 and gave the company an “overweight” rating in a research note on Wednesday, November 5th. Royal Bank Of Canada started coverage on Sotera Health in a research report on Thursday, January 8th. They set an “outperform” rating and a $24.00 price objective for the company. Finally, BMO Capital Markets assumed coverage on Sotera Health in a report on Thursday, November 13th. They issued an “outperform” rating and a $19.00 price objective on the stock. One equities research analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating and two have assigned a Hold rating to the company. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $20.00.

Sotera Health Stock Up 1.6%

Shares of NASDAQ SHC opened at $18.98 on Thursday. The business has a 50-day moving average price of $17.44 and a 200 day moving average price of $15.77. The stock has a market cap of $5.39 billion, a PE ratio of 99.90 and a beta of 1.82. The company has a quick ratio of 2.18, a current ratio of 2.38 and a debt-to-equity ratio of 4.04. Sotera Health Company has a 52-week low of $9.53 and a 52-week high of $19.85.

Sotera Health (NASDAQ:SHC) last issued its quarterly earnings data on Tuesday, November 4th. The company reported $0.26 earnings per share for the quarter, beating analysts’ consensus estimates of $0.22 by $0.04. The company had revenue of $311.31 million during the quarter, compared to analysts’ expectations of $303.63 million. Sotera Health had a return on equity of 43.69% and a net margin of 4.82%.Sotera Health has set its FY 2025 guidance at 0.810-0.860 EPS. Equities research analysts forecast that Sotera Health Company will post 0.61 earnings per share for the current year.

Insider Buying and Selling

In related news, Director Pincus & Co. Warburg sold 9,720,000 shares of the business’s stock in a transaction dated Wednesday, December 3rd. The stock was sold at an average price of $16.33, for a total value of $158,727,600.00. Following the transaction, the director owned 34,102,952 shares in the company, valued at $556,901,206.16. The trade was a 22.18% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, Director Gtcr Investment Xi Llc sold 12,000,000 shares of Sotera Health stock in a transaction that occurred on Monday, November 10th. The shares were sold at an average price of $15.65, for a total value of $187,800,000.00. Following the completion of the transaction, the director owned 29,215,301 shares in the company, valued at $457,219,460.65. This trade represents a 29.12% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 29,384,104 shares of company stock valued at $471,824,511 over the last quarter. 47.55% of the stock is currently owned by insiders.

About Sotera Health

Sotera Health Inc (NASDAQ: SHC) is a global provider of sterilization and laboratory testing services that support the medical device, pharmaceutical, life sciences and consumer product industries. Headquartered in Jacksonville, Florida, the company offers a suite of services designed to ensure products meet rigorous safety and regulatory requirements before reaching market.

Sotera Health operates through three primary service platforms. Its Sterigenics division delivers contract sterilization solutions, including ethylene oxide (EtO), gamma irradiation, electron beam and X-ray technologies.